Radiopharm Theranostics (ASX:RAD, ‘Radiopharm’ or the ‘Company’), a clinical-stage biopharmaceutical company focused on developing innovative oncology radiopharmaceuticals for areas of high unmet medical need, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation for RAD101 to distinguish between recurrent disease and treatment effect of…
Energy sector innovators took center stage on Wednesday (June 11), with Eclipse Automation securing major deals in nuclear infrastructure,…
Peter Krauth, editor of Silver Stock Investor and Silver Advisor, outlines the factors driving silver’s recent price run, which…
E-Power Resources Inc (CSE: EPR) (FSE: 8RO) (‘E-Power’ or the ‘Company’) announces its intention to complete a flow-through non-brokered…
Juggernaut Exploration (TSXV: UGR,OTCQB:JUGRF,FSE:4JE) is a precious metals exploration company focused on British Columbia’s Golden Triangle — a world-renowned…
FireFly Metals (ASX:FFM,TSX:FFM,OTC Pink:MNXMF) has attained firm commitments to raise up to about AU$95 million, giving it a total…
Chris Blasi, president of Neptune Global, believes gold still has much more room to run. ‘Some people think gold…
As global automakers brace for fallout from China’s tightening grip on rare earths exports, Hyundai Motor (KRX:005380,OTC Pink:HYMTF) appears…